Press Releases Novo Nordisk A/S BOERSE MUENCHEN

Equities

NOVA

US6701002056

Real-time BOERSE MUENCHEN Other stock markets 01:21:25 05/07/2024 am IST			5-day change	1st Jan Change
130.5 ^EUR	+0.77%		-3.33%	+39.42%

04/07	ETF of the week: Investing in strong trends with the momentum theme
04/07	NOVO NORDISK : Deutsche Bank remains its Buy rating	ZD

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Holdings invests in MATR Foods expansion within plant-based fungi food	02/07	AQ
Novo Nordisk A/S - share repurchase programme	01/07	GL
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss	26/06	GL
New US fill finish facility receives $4.1 billion investment	26/06	AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery	26/06	AQ
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	24/06	GL
Novo Nordisk A/S - share repurchase programme	24/06	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	18/06	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	18/06	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	17/06	AQ
Novo Nordisk A/S - share repurchase programme	17/06	GL
Haemophilia drug could reduce treated bleeding episodes	13/06	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	11/06	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	11/06	AQ
Novo Nordisk A/S - share repurchase programme	10/06	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Novo Nordisk A/S - share repurchase programme	03/06	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
Novo Nordisk A/S - share repurchase programme	27/05	GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05	AQ